Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Geron Corp. buy klostergang

Geron Corp.
Start price
€3.58
26.06.15 / 50%
Target price
€4.50
07.12.15
Performance (%)
29.46%
End price
€4.63
07.12.15
Summary
This prediction ended on 07.12.15 with a price of €4.63. The prediction had a final performance of 29.46%. klostergang has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Geron Corp. 17.121% 17.121% 16.127% -20.032%
iShares Core DAX® 0,23 % -2,41 % 15,34 % 45,10 %
iShares Nasdaq 100 1,66 % -1,66 % 31,09 % 76,36 %
iShares Nikkei 225® -0,21 % -2,50 % 43,63 % 49,59 %
iShares S&P 500 1,07 % -1,58 % 24,35 % 57,07 %

Comments by klostergang for this prediction

In the thread Geron Corp. diskutieren
Prediction Buy
Perf. (%) 29.46%
Target price 4.500
Change
Ends at 07.12.15

Mit JNJ-Partnerschaft und Orphan Drug der FDA gegen Krebs :

Geron Corp is a clinical stage biopharmaceutical company engaged in the discovery and development of therapeutic products for oncology such as telomerase inhibitor, imetelstat and in hematologic myeloid malignancies, among others.

klostergang 
0
Report Share
26.06.15
Prediction Buy
Perf. (%) 29.46%
Target price 4.500
Change
Ends at 07.12.15

(Vom Mitglied beendet)

klostergang 
0
Report Share
07.12.15